| Old Articles: <Older 48031-48040 Newer> |
|---|
 |
BusinessWeek
April 14, 2011
Rachel Layne |
GE and Siemens: Less May Mean More (Profits) The medical gear makers see an opportunity for their information technology units as hospitals are pressured to improve efficiency and curb waste   |
BusinessWeek
April 14, 2011
Alexander & David |
Goldman Sachs Finds It Slow Going in India While the economy is surging, fees are low and competition intense |
BusinessWeek
April 14, 2011
David Welch |
For Investors, the Shine Is Off the New GM The Detroit giant's shares have sunk below their IPO price |
The Motley Fool
April 14, 2011
Christopher Barker |
Your Sneak Preview of the Next Silver Bonanza Continued margin expansion continues to spell a bonanza for silver miners. |
The Motley Fool
April 14, 2011
Travis Hoium |
California Makes a Splash in Solar California is taking concrete steps to become solar's next big demand source. |
The Motley Fool
April 14, 2011
Rex Moore |
April's "Foolish 8" Stocks Here are five small-caps with outstanding potential. |
The Motley Fool
April 14, 2011
Chris Hill |
Two Hot IPOs, But Only One Worth Watching We have things to say about Zipcar, Arcos Dorados, and Hasbro. |
The Motley Fool
April 14, 2011
Arlene Weintraub |
Acorda Stock Halted as Shares Skyrocket on Patent Speculation RBC Capital Markets are suggesting good things for the company's MS drug. |
The Motley Fool
April 14, 2011
Anders Bylund |
Fairchild Should Swing That Cost-Cutting Axe The semiconductor company should cut costs before this window closes. |
The Motley Fool
April 14, 2011
Brian Orelli |
Human Genome Sciences Will Be Profitable, Eventually With its first drug on the market -- nearly 20 years after the company was founded -- Human Genome Sciences should start to show meaningful revenue this year. |
| <Older 48031-48040 Newer> Return to current articles. |
